Skip to content

Cancer Loyalty Card Study (CLOCS): aiming to reduce delays in cancer diagnosis using everyday data

Cancer Loyalty Card Study (CLOCS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14897082
Enrollment
1000
Registered
2019-10-29
Start date
2019-11-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer Cancer Malignant neoplasm of ovary

Interventions

Eligible participants will be women in the UK who own at least one loyalty card with the participating high street retailers. Of these women, those who have been diagnosed with ovarian cancer are elig

Sponsors

Imperial College of Science, Technology and Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women, at least 18 years old, recently diagnosed with ovarian cancer (preferably recruited just after diagnosis and during treatment period, but are still eligible if diagnosed up to 2 years prior, at the latest) who hold at least one participating high street retailer loyalty card are eligible to join the CLOCS as cases 2. Women, at least 18 years old, who have not been diagnosed with ovarian cancer and hold at least one participating high street retailer loyalty card are eligible to join the CLOCS as controls

Exclusion criteria

Exclusion criteria: 1. Women under the age of 18 years 2. Men

Design outcomes

Primary

MeasureTime frame
The time by which the cases and controls are statistically significantly different in their purchase behaviours leading up to diagnosis on a population level. Method: Data will be collected using questionnaire to establish ovarian cancer risk factors and clinical information; high street retailer loyalty cards data will be collected to establish an individual’s purchases and purchase behaviours. Timepoints: Participants will be recruited at baseline, and data collected at one timepoint (date of recruitment), and all data available up until that timepoint will be analysed.

Secondary

MeasureTime frame
The purchase threshold defined as an “alert” about cancer symptoms in individuals and the predictive utility of purchasing behaviours in the early detection of ovarian cancer. Exploratory analyses will include longitudinal analyses, frequency of purchases and unbiased analysis of other purchase categories. Method: Data will be collected using questionnaire to establish ovarian cancer risk factors and clinical information; high street retailer loyalty cards data will be collected to establish an individual’s purchases and purchase behaviours; Timepoints: Participants will be recruited at baseline, and data collected at one timepoint (date of recruitment), and all data available up until that timepoint will be analysed.

Countries

England, Scotland, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 9, 2026